Media Summary: Dr. George Demetri, Medical Oncologist, explains why Amy Bessnow, MD, MPH, is a lymphoma physician in The balance between science and clinical care that distinguishes

Dana Farber Cancer Institute - Detailed Analysis & Overview

Dr. George Demetri, Medical Oncologist, explains why Amy Bessnow, MD, MPH, is a lymphoma physician in The balance between science and clinical care that distinguishes Jacob Laubach, MD, MPP, and Constantine S. Mitsiades, MD, PhD, provide an overview on multiple myeloma. They cover what it ... Harold Burstein, MD, PhD; Sara Tolaney, MD, MPH; Nancy Lin, MD; Sarah Sammons, MD; Ana C. Garrido-Castro, MD; and ... Harold Burstein, MD, PhD; Sara Tolaney, MD, MPH; Nancy Lin, MD; Filipa Lynce, MD; and Ana C. Garrido-Castro, MD discuss ...

Nancy Lin, MD, director, and Sarah Sammons, MD, associate director of the Metastatic Breast Philippe Armand, MD, PhD, Chief of the Lymphoma Division, shares information on what to know about lymphoma. He discusses ...

Photo Gallery

Welcome to Dana-Farber Cancer Institute
Dana-Farber Cancer Institute retracts 7 studies
Our Vision for the Future of Cancer Care | Dana-Farber Cancer Institute
A Virtual Tour of Dana-Farber Cancer Institute – Longwood Campus
Welcome to Dana-Farber Cancer Institute
Reflections on Working at Dana-Farber Cancer Institute
What We Do Here Changes Lives Everywhere | Dana-Farber Cancer Institute
Working at Dana-Farber | Dana-Farber Cancer Institute
Amy Bessnow, MD, MPH, on Lymphoma Treatment | Dana-Farber Cancer Institute
I Am Here Because of Dana-Farber – TV | Dana-Farber Cancer Institute
Multiple Myeloma 101 for 2025: Diagnosis, Prognosis, and Risk
SABCS 2025 Breast Cancer Highlights Panel Discussion | Dana-Farber Cancer Institute
Sponsored
Sponsored
View Detailed Profile
Welcome to Dana-Farber Cancer Institute

Welcome to Dana-Farber Cancer Institute

At

Dana-Farber Cancer Institute retracts 7 studies

Dana-Farber Cancer Institute retracts 7 studies

The

Sponsored
Our Vision for the Future of Cancer Care | Dana-Farber Cancer Institute

Our Vision for the Future of Cancer Care | Dana-Farber Cancer Institute

Dana

A Virtual Tour of Dana-Farber Cancer Institute – Longwood Campus

A Virtual Tour of Dana-Farber Cancer Institute – Longwood Campus

Come and take a virtual tour of

Welcome to Dana-Farber Cancer Institute

Welcome to Dana-Farber Cancer Institute

At

Sponsored
Reflections on Working at Dana-Farber Cancer Institute

Reflections on Working at Dana-Farber Cancer Institute

In this series, we interviewed

What We Do Here Changes Lives Everywhere | Dana-Farber Cancer Institute

What We Do Here Changes Lives Everywhere | Dana-Farber Cancer Institute

Dr. George Demetri, Medical Oncologist, explains why

Working at Dana-Farber | Dana-Farber Cancer Institute

Working at Dana-Farber | Dana-Farber Cancer Institute

This introduction to

Amy Bessnow, MD, MPH, on Lymphoma Treatment | Dana-Farber Cancer Institute

Amy Bessnow, MD, MPH, on Lymphoma Treatment | Dana-Farber Cancer Institute

Amy Bessnow, MD, MPH, is a lymphoma physician in

I Am Here Because of Dana-Farber – TV | Dana-Farber Cancer Institute

I Am Here Because of Dana-Farber – TV | Dana-Farber Cancer Institute

The balance between science and clinical care that distinguishes

Multiple Myeloma 101 for 2025: Diagnosis, Prognosis, and Risk

Multiple Myeloma 101 for 2025: Diagnosis, Prognosis, and Risk

Jacob Laubach, MD, MPP, and Constantine S. Mitsiades, MD, PhD, provide an overview on multiple myeloma. They cover what it ...

SABCS 2025 Breast Cancer Highlights Panel Discussion | Dana-Farber Cancer Institute

SABCS 2025 Breast Cancer Highlights Panel Discussion | Dana-Farber Cancer Institute

Harold Burstein, MD, PhD; Sara Tolaney, MD, MPH; Nancy Lin, MD; Sarah Sammons, MD; Ana C. Garrido-Castro, MD; and ...

Strength Training for Osteoporosis (15 min) | Dana-Farber Zakim Center Remote Programming

Strength Training for Osteoporosis (15 min) | Dana-Farber Zakim Center Remote Programming

Research

ESMO25 Breast Cancer Highlights Panel Discussion | Dana-Farber Cancer Institute

ESMO25 Breast Cancer Highlights Panel Discussion | Dana-Farber Cancer Institute

Harold Burstein, MD, PhD; Sara Tolaney, MD, MPH; Nancy Lin, MD; Filipa Lynce, MD; and Ana C. Garrido-Castro, MD discuss ...

Dana-Farber Cancer Institute gets state approval to build hospital

Dana-Farber Cancer Institute gets state approval to build hospital

Dana

Breakthroughs – TV | Dana-Farber Cancer Institute

Breakthroughs – TV | Dana-Farber Cancer Institute

For nearly 80 years,

What is Metastatic Breast Cancer? | Dana-Farber Cancer Institute

What is Metastatic Breast Cancer? | Dana-Farber Cancer Institute

Nancy Lin, MD, director, and Sarah Sammons, MD, associate director of the Metastatic Breast

What to Know About Lymphoma | Dana-Farber Cancer Institute

What to Know About Lymphoma | Dana-Farber Cancer Institute

Philippe Armand, MD, PhD, Chief of the Lymphoma Division, shares information on what to know about lymphoma. He discusses ...